Aspirin Underutilized for Preeclampsia Prevention
MONDAY, Jan. 31, 2022 (HealthDay News) -- Aspirin use is underused for preeclampsia prophylaxis in women with prepregnancy diabetes, obesity, or chronic hypertension or a combination of these factors, according to a research letter published in the Jan. 25 issue of the Journal of the American Medical Association.
Joel G. Ray, M.D., from St. Michael's Hospital in Toronto, and colleagues used data from the Better Outcomes Registry and Network to identify women with a hospital livebirth or stillbirth at ≥23 weeks of gestation (371,237 births; April 1, 2018, through Dec. 31, 2020) to estimate aspirin use for preeclampsia prevention in pregnant women with prepregnancy diabetes, obesity, chronic hypertension, and combinations of these factors.
The researchers found that aspirin was used by 3.2 percent of women without any of the three risk factors versus 17.2 percent of women with diabetes, 6.9 percent of women with obesity, and 27.6 percent of women with hypertension. For women with diabetes and obesity, the rate of aspirin use was 22.2 percent versus 36.6 percent in women with diabetes and hypertension, 32.3 percent in women with obesity and hypertension, and 38.8 percent in women with all three factors.
"For the 2021 U.S. Preventive Services Task Force recommendations to be more influential, more data are needed to characterize barriers for aspirin adoption among suitable women at the patient and practitioner level, and additional knowledge translation initiatives developed," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Americans’ Odds for Parkinson’s May Be Higher Than Thought
THURSDAY, Dec. 15, 2022 (HealthDay News) -- Parkinson's disease is a much bigger...
Pfizer Asks FDA to Approve Tweaked COVID Booster as Third Shot for Kids Under 5
MONDAY, Dec. 5, 2022 (HealthDay News) -- Infants and young children could soon...
Adherence to Mediterranean Diet Linked to Lower CVD, Mortality in Women
WEDNESDAY, March 15, 2023 (HealthDay News) -- For women, adherence to a...
AI Can Estimate Best-Corrected Visual Acuity With Diabetic Macular Edema
MONDAY, June 12, 2023 (HealthDay News) -- Artificial intelligence...